Just wanted to highlight that residential sales nos released for Apr/May across four key Indian cities (Mumbai, Gurgaon, Bangalore, Chennai) have picked up marginally by 3% Q/Q.This follows a 10-15% Q/Q volume decline witnessed in 1Q2010. While still early days, data shows that volume trends across markets now seem to be stabilizing at 1Q10 levels. This is consistent with guidance coming out of major property companies that overall they will look to sustain Jan-Mar Q run rate levels going into FY11 and the peak in terms of volumes is clearly behind us. Within the respective markets , Mumbai has fared the worst with volumes in Apr/May down 14% Q/Q .However sales in other markets (Gurgaon, Bangalore, Chennai) have increased 2-23% Q/Q. Overall on a 5Month YTD (CY10) basis, absorption run rate in Mumbai is down ~20% as compared to CY09, whereas it is largely stable in other cities. Average monthly absorption trends Source: Propequity Pricing in Mumbai/NCR continues to hold firm as months of inventory (Unsold Stock /Avg 3 Month sales) remains relatively low (7-10 months) . Bangalore/Chennai however still have 12-14 months of unsold inventory which is as yet restricting any meaningful price appreciation in these markets despite positive absorption trends at the margin. Mumbai volumes down 14% Q/Q: Mumbai (ex Navi Mumbai/Thane) recorded average monthly unit sales of 1,838 units/month in Apr/May which is 14%/26% below from 1Q10/4Q09 average. 5M YTD (2010) absorption run rate is down ~20% as compared to 2009. Volume slowdown can be attributable to sharp price increases over the last year and seasonally weak period. Months of unsold inventory too has started to inch up (10 months vs. 9 months as of 1Q10) given high launch activity despite volume slowdown. Pricing however continues to remain stable across markets. Mumbai: Monthly absorption and months of inventory Source: Prop Equity, JP Morgan Gurgaon absorption stabilizing, months of unsold inventory at 2 year low: Average monthly absorption of 2,176 units/months recorded in Apr/May is 9% higher than 1Q average. YTD the overall monthly absorption run rate is largely stable at CY009 levels. Months of unsold inventory (~7 months) continued to decline in the market and is currently at its two year low thereby keeping pricing relatively strong. Gurgaon: Monthly absorption and months of inventory Source: Prop Equity, JP Morgan Southern cities (Bangalore/Chennai) witnessing healthy absorption trends with average sales run rate over Apr/May increasing by 5-20% from 1Q10 levels. Over Apr/May, Bangalore recorded average monthly absorption of 1,820 units (up 2% Q/Q, up 21% Y/Y), while Chennai recorded average monthly absorption of 1,307 units (up 23% Q/Q, flat Y/Y). Months of unsold inventory continued to decline across these markets, however it is still running at high levels of 12-14 months thereby restricting any meaningful price appreciation in these markets as yet. Bangalore: Monthly absorption and months of inventory Source: Prop Equity, JP Morgan Chennai: Monthly absorption and months of inventory Source: Prop Equity, JP Morgan
| | | | | | | | I certify that all of the views expressed in this research email accurately reflect my personal views about any and all of the subject securities or issuers; and that no part of my compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed herein. This email communication is for informational purposes only. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Opinions, estimates and assumptions expressed herein are made as of the date of this communication and are subject to change without notice. This email communication has been prepared based upon information, including market prices, data and other information, believed to be reliable; however, J.P. Morgan does not warrant its completeness or accuracy. Past performance is not indicative of future results. Before making an investment decision regarding any security or company referred in this email communication, you should refer to the most recent published research for the views and analysis of the analyst, including the investment thesis and valuation and risk, regarding such security or company. Additional information is available upon request. Confidentiality and Security Notice: This transmission may contain information that is privileged, confidential, legally privileged, and/or exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or use of the information contained herein (including any reliance thereon) is STRICTLY PROHIBITED. Although this transmission and any attachments are believed to be free of any virus or other defect that might affect any computer system into which it is received and opened, it is the responsibility of the recipient to ensure that it is virus free and no responsibility is accepted by JPMorgan Chase & Co., its subsidiaries and affiliates, as applicable, for any loss or damage arising in any way from its use. If you received this transmission in error, please immediately contact the sender and destroy the material in its entirety, whether in electronic or hard copy format. | | | |
|
|
0 comments:
Post a Comment